Pharmacokinetic/pharmacodynamics (PK/PD), as integral components of the drug development process

Introduction to Quantitative Clinical Pharmacology (Part 1)

Tarifs

2090 €
1820 € par module dans le cadre d'un parcours Pass'Compétences

Durée

30 heures (eLearning)

Dates

Référence FCS21-0092A :
du 01/04/2022 au 30/04/2022

Lieu de la formation

A distance

Renseignements & inscriptions

Frédérique COSTES 03 68 85 49 27

Sauf le mercredi après-midi et le vendredi

Accueil des personnes en situation de handicap

Le Service de la vie universitaire – Mission handicap propose un dispositif d’accueil et d’accompagnement spécifique pour permettre aux personnes en situation de handicap de se former dans les meilleures conditions possibles. Pour en savoir plus

Toute demande d’adaptation peut être étudiée en amont de la formation, en fonction du besoin.

Merci de vous adresser au correspondant handicap du SFC
M. Dominique Schlaefli (dominique.schlaefli@unistra.fr)

Certifications & Homologation

Vos interlocuteurs

This training is the first part of the graduate education in Pharmacometrics from the University of Strasbourg

Compétences à l'issue de la formation

  • Recognize different types of pharmacodynamics endpoints.
  • Distinguish different temporal relationships between pharmacokinetics and pharmacodynamics.
  • Able to identify proper class of PK/PD models to describe different PK/PD relationships.
  • Describe examples on the application of PK/PD analysis in drug development.
  • Develop Population PK/PD analysis and PK/PD modeling and Use R-Pharma in various situations.
  • Create own PK/PD concept in clinical practice and/or in drug development.
Prospectives attendees
expand_more

Pharmacists, pharmacologists, physicians, veterinaries, statisticians, engineers, researchers from academies, and hospital/industrial workers.

Professionals with at least a masters with some experience in drug development should apply.

Content
expand_more

Principles of clinical pharmacology and their application to clinical development in oncology and cardiovascular diseases :

– The scientific principles, techniques and approaches used to study the pharmacology of oncology and cardiovascular systems at the molecular, cellular, tissue/organ and whole organism levels, including what constitutes good experimental design and how data are translated to man

– The current therapeutic approaches used to treat cardiovascular and oncology disease and their advantages and disadvantages

– Possible future developments in the pharmacological management of cardiovascular and oncology disease.

This course could will be follow to the hands-on session describe in details in module 2: Pharmacometrics: modeling and simulation tools.

Teaching methods
expand_more

All courses will be in English and be designed and delivered by distance-learning. The e-learning sessions will be held on the DigitalUni platform specifically developed for continuing education.

For technical information and prerequisites, please contact sfc-ead@unistra.fr

Informations
expand_more

This training course is an « action d’adaptation et de développement des compétences » (ref. French law). A certificate of attendance is delivered after the course. An evaluation measures the trainees’ satisfaction and the achievement of learning objectives.

Study director
expand_more

Dr. Geneviève Ubeaud-Séquier, Professor of Pharmacokinetics in faculty of Pharmacy and Hospital Pharmacist – Strasbourg University

Email : ubeaud@unistra.fr

Pass'Compétences Universitaire
expand_more

This training is the first part of the graduate Education in Pharmacometrics from the University of Strasbourg.

Vous êtes une organisation et souhaitez une proposition intra pour cette formation ?

Vous êtes une organisation et souhaitez un accompagnement dans la construction de votre projet sur-mesure.